XAMOXA, created in 2006 (Switzerland), from 2951 sister brands and 17477 competing brands. XAMOXA is a brand of NOVARTIS N, listed on the stock exchange of Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. The sector of XAMOXA is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(XAMOXA)
over 5 years*
CHF 99.86